{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:33:49Z","timestamp":1778600029970,"version":"3.51.4"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"DOI":"10.1001\/jama.279.20.1613-a","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T06:14:54Z","timestamp":1047968094000},"page":"1613","source":"Crossref","is-referenced-by-count":28,"title":["Toxic Epidermal Necrolysis From Atorvastatin"],"prefix":"10.1001","volume":"279","author":[{"given":"Constance M.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kazenoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey D.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[1998,5,27]]},"reference":[{"key":"REF-JLT0527-7-1-1","unstructured":"POFritschPMEliasErythema multiforme and toxic epidermal necrolysis.FitzpatrickTBEisenAZWolffKFreedbergIMAustenKFeds.Dermatology in General Medicine.New York, NYMcGraw-Hill Book Co1993585599"},{"key":"REF-JLT0527-7-1-2","unstructured":"PANowakowskiJARumsfieldDPWestDrug-induced skin disorders.DiPiroJTTalbertRLYeeGCeds.Pharmacotherapy: A Pathophysiologic Approach.East Norwalk, ConnAppleton & Lange199318351844"},{"key":"REF-JLT0527-7-1-3","unstructured":"JCRoujeauRSSternSevere adverse cutaneous reactions to drugs.N Engl J Med.199433112721285"},{"key":"REF-JLT0527-7-1-4","unstructured":"JCRoujeauJPKellyNLuigiMedication use and the risk of Stevens-Johnson syndrome or toxic epidermal\nnecrolysis.N Engl J Med.199533316001607"},{"key":"REF-JLT0527-7-1-5","unstructured":"RGBakker-ArkemaMHDavidsonRJGoldsteinEfficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin,\nin patients with hypertriglyceridemia.JAMA.1996275128133"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/1152151\/jlt0527.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:31:36Z","timestamp":1764952296000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1152151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,27]]},"references-count":5,"journal-issue":{"issue":"20","published-print":{"date-parts":[[1998,5,27]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.279.20.1613-a","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5,27]]}}}